Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-25-037713
Filing Date
2025-04-30
Accepted
2025-04-30 17:00:11
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K ea0239596-10ka1_therapeutics.htm   iXBRL 10-K/A 258388
2 CERTIFICATION ea023959601ex31-1_therape.htm EX-31.1 4064
3 CERTIFICATION ea023959601ex31-2_therape.htm EX-31.2 4139
4 GRAPHIC image_001.jpg GRAPHIC 8124
  Complete submission text file 0001213900-25-037713.txt   636565

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE txmd-20241231.xsd EX-101.SCH 3443
6 XBRL LABEL FILE txmd-20241231_lab.xml EX-101.LAB 877
7 XBRL PRESENTATION FILE txmd-20241231_pre.xml EX-101.PRE 1299
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0239596-10ka1_therapeutics_htm.xml XML 7751
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-00100 | Film No.: 25896602
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)